Browse Title Index
Issue Title
Vol 2, No 3 (2011) Secondary acute myeloid leukemia with monosomy 7 in Ph-negative cells in a patient with chronic myeloid leukemia in chronic phase Abstract   PDF (Polish)
Elżbieta Patkowska, Przemysław Juszczyński, Katarzyna Borg, Iwona Solarska, Monika Prochorec-Sobieszek, Krzysztof Warzocha
Vol 12, No 1 (2021) Secondary immune thrombocytopenia after Streptococcus infection Abstract   PDF
Katarzyna Korzeniowska, Artur Cieślewicz, Irmina Wietlicka, Anna Jabłecka
Vol 1, No 3 (2010) Selection pressure phenomenon during treatment of chronic myeloid leukemia patients with BCR-ABL1 tyrosine kinase inhibitors: problem analysis on the basis of case report Abstract   PDF (Polish)
Krzysztof Lewandowski, Anna Wache
Vol 2, No 1 (2011) Severe vitamin B12 deficiency of unknown origin in 10-months-old girl Abstract   PDF (Polish)
Małgorzata Zubowska, Beata Zalewska-Szewczyk, Wanda Stengert, Katarzyna Mycko, Wojciech Młynarski
Vol 9, No 2 (2018) Significance of minimal residual disease assessment in patients with chronic lymphocytic leukemia Abstract   PDF (Polish)
Bartosz Puła, Adrian Burdacki, Marek Dudziński
Vol 9, No 3 (2018) Significance of minimal residual disease evaluation in AL amyloidosis Abstract   PDF (Polish)
Agnieszka Krzywdzińska, Iwona Solarska, Bartosz Puła, Krzysztof Jamroziak
Vol 12, Supp. B (2021) Skirmishes with primary immune thrombocytopenia Abstract   PDF (Polish)
Justyna Gil
Vol 8, Supp. B (2017) Skuteczne leczenie nilotynibem pacjenta z rozpoznaniem przewlekłej białaczki szpikowej po niepowodzeniu terapii imatynibem i nietolerancji dazatynibu Abstract   PDF (Polish)
Magdalena Hałasz
Vol 8, Supp. B (2017) Skuteczność i bezpieczeństwo stosowania nilotynibu w leczeniu przewlekłej białaczki szpikowej współistniejącej z cukrzycą typu 2 Abstract   PDF (Polish)
Katarzyna Kotwica-Mojzych, Mariusz Mojzych, Barbara Jodłowska-Jędrych, Marek Hus
Vol 8, Supp. B (2017) Skuteczność inhibitorów kinazy tyrozynowej po wieloletniej terapii cytoredukcyjnej w przebiegu przewlekłej białaczki szpikowej Abstract   PDF (Polish)
Małgorzata Raźny, Paweł Szwedyk
Vol 8, Supp. C (2017) Skuteczność terapii ruksolitynibem u pacjentki z mielofibrozą wtórną do czerwienicy prawdziwej Abstract   PDF (Polish)
Anna Masternak, Dariusz Woszczyk
Vol 5, No 3 (2014) Splenectomy for primary immune thrombocytopenia in adults Abstract   PDF (Polish)   HTML (Polish)
Krzysztof Chojnowski
Vol 14 (2023): Continuous Publishing Study of type and frequency of Alfa-thalassemia mutations in a cohort of 3,823 patients from Isfahan Province, Iran Abstract   PDF   HTML
Parvaneh Tavakoli Afshar, Zohreh Taherian, Negar Nouri, Erfan Zaker, Sara Asadi, Farzaneh Rami, Roya Bakhtiari, Majid Hosseinzadeh, Mansoor Salehi
Vol 8, No 2 (2017) Successful induction and consolidation chemotherapy in 20-years-old woman with acute promyelocytic leukemia who refused to accept blood transfusion because of religious beliefs Abstract   PDF (Polish)   HTML (Polish)
Ilona Szypuła-Perkosz, Ewa Bodzenta, Agnieszka Barchnicka, Elżbieta Chachaj, Janusz Limon, Bożena Jaźwiec, Sebastian Grosicki
Vol 3, No 1 (2012) Successful myeloablative allogeneic hematopoietic stem cell transplantation in patient with acute myeloid leukemia and preexisting pulmonary aspergillosis Abstract   PDF (Polish)
Anna Ejduk, Agnieszka Tomaszewska, Bożena Mariańska, Ewa Lech-Marańda, Krzysztof Warzocha
Vol 11, Supp. A (2020) Successful nilotinib cessation after imatinib therapy failure Abstract   PDF (Polish)
Joanna Wącław, Tomasz Sacha
Vol 11, Supp. A (2020) Successful nilotinib cessation after imatinib therapy intolerance Abstract   PDF (Polish)
Joanna Wącław, Tomasz Sacha
Vol 4, Supp. B (2013) Successful nilotinib therapy in the patient with chronic myelogenous leukemia with secondary resistance to imatinib Abstract   PDF (Polish)
Ilona Seferyńska, Krzysztof Warzocha
Vol 2, Supp. B (2011) Successful nilotinib therapy in the patient with suboptimal response of chronic myeloid leukemia to imatinib treatment associated with non-hematological toxicity Abstract   PDF (Polish)
Tomasz Sacha
Vol 9, Supp. A (2018) Successful nilotinib treatment in a patient with chronic myelogenous leukemia after failure of treatment with two tyrosine kinase inhibitors due to intolerance and resistance Abstract   PDF (Polish)
Edyta Paczkowska
Vol 3, No 3 (2012) Successful therapy with dasatinib in patient with recurrent liver toxicity associated with imatinib and nilotinib administration Abstract   PDF (Polish)
Tomasz Sacha
Vol 6, No 2 (2015) Successful treatment with dasatinib of 18-years-old patient with chronic myelogenous leukemia who relapsed after the 1st-line therapy with imatinib Abstract   PDF (Polish)   HTML (Polish)
Ilona Seferyńska, Krzysztof Warzocha
Vol 2, Supp. B (2011) Successful treatment with nilotinib due to chronic myeloid leukemia in the patient previously treated with imatinib that was complicated by aplastic anemia Abstract   PDF (Polish)
Kinga Kos-Zakrzewska
Vol 2, Supp. A (2011) Suplement A Details   PDF (Polish)
Redakcja Hematologii
Vol 6, No 3 (2015) Systemic challenges facing the hematological oncology in the context of an aging population in Poland Abstract   PDF (Polish)   HTML (Polish)
Jakub Gierczyński, Ewa Lech-Marańda, Małgorzata Gałązka-Sobotka, Jerzy Gryglewicz, Joanna Didkowska, Urszula Wojciechowska, Krzysztof Warzocha
401 - 425 of 543 Items <<   <   12 13 14 15 16 17 18 19 20 21   >   >> 

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl